Quest Diagnostics Inc Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date
Quest Diagnostics Inc (DGX) had Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date of 450 positions as of 2013-09-30, per its 10-Q filed 2013-10-24.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedInceptionToDate · last filed 2013-10-24
- 2013-09-30: Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date 450.00 positions.
- 2013-06-30: Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date 450.00 positions.
| Period end | Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date |
|---|---|
| 2013-09-30 | 450.00 positions 10-Q · filed 2013-10-24 |
| 2013-06-30 | 450.00 positions 10-Q · filed 2013-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |